3.239.76.25
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Gastroenterology

Dapagliflozin shows positive impact on type 2 diabetes and non-alcoholic fatty liver disease

Dapagliflozin demonstrates significant benefits in improving hepatic function and glucose control in patients with type 2 diabetes and non-alcoholic fatty liver disease (NAFLD), according to a meta-analysis. The study, which included 4 randomized controlled trials, found that dapagliflozin treatment led to a notable reduction in key markers such as alanine...

Read More
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-